The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Brigham Young University researchers are leading a significant validation study of a blood test designed to detect ...

Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, today, at the 43rd annual J.P. Morgan Healthcare Conference. In addition to ...

A UCSF study reveals that maternal X chromosome expression may accelerate brain aging and cognitive decline. Female mice with ...

Heroes, Warriors, and Martyrs—are biologically imprinted in our DNA, and how science, psychology, and epigenetics reveal the roots of human behavior.

Many of them can be applied to the detection of circulating cell-free DNA (cfDNA) released by cancer cells in the blood. Especially the detection of cfDNA methylation levels can be achieved by ...

Particularly noteworthy is the analysis of cell-free DNA (cfDNA) methylation, which provides a non-invasive means to reflect disease mechanisms. In DR-TLE, cfDNA methylation patterns show significant ...

Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...